Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Suh, Dong Hoon | - |
dc.contributor.author | Chang, Suk-Joon | - |
dc.contributor.author | Song, Taejong | - |
dc.contributor.author | Lee, Sanghoon | - |
dc.contributor.author | Kang, Woo Dae | - |
dc.contributor.author | Lee, Sun Joo | - |
dc.contributor.author | Roh, Ju-Won | - |
dc.contributor.author | Joo, Won Duk | - |
dc.contributor.author | Yoon, Joo Hee | - |
dc.contributor.author | Jeong, Dae Hoon | - |
dc.contributor.author | Kim, Hee Seung | - |
dc.contributor.author | Lee, Sung Jong | - |
dc.contributor.author | Ji, Yong Il | - |
dc.contributor.author | Kim, Hyun-Jung | - |
dc.contributor.author | Lee, Jeong-Won | - |
dc.contributor.author | Kim, Jae-Weon | - |
dc.contributor.author | Bae, Duk-Soo | - |
dc.date.accessioned | 2021-09-02T09:55:24Z | - |
dc.date.available | 2021-09-02T09:55:24Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-07 | - |
dc.identifier.issn | 2005-0380 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/74870 | - |
dc.description.abstract | Since after 2006 when the first edition of practice guidelines for gynecologic oncologic cancer treatment was released, the Korean Society of Gynecologic Oncology (KSGO) has published the following editions on a regular basis to suggest the best possible standard care considering updated scientific evidence as well as medical environment including insurance coverage. The Guidelines Revision Committee was summoned to revise the second edition of KSGO practice guidelines, which was published in July 2010, and develop the third edition. The current guidelines cover strategies for diagnosis and treatment of primary and recurrent ovarian cancer. In this edition, we introduced an advanced format based on evidence-based medicine, collecting up-to-date data mainly from MEDLINE, EMBASE, and Cochrane Library CENTRAL, and conducting a meta-analysis with systematic review. Eight key questions were raised by the committee members. For every key question, recommendations were developed by the consensus meetings and provided with evidence level and strength of the recommendation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY | - |
dc.subject | PEGYLATED LIPOSOMAL DOXORUBICIN | - |
dc.subject | RECURRENT EPITHELIAL OVARIAN | - |
dc.subject | PLATINUM-RESISTANT OVARIAN | - |
dc.subject | PHASE-III TRIAL | - |
dc.subject | QUALITY-OF-LIFE | - |
dc.subject | PRIMARY PERITONEAL | - |
dc.subject | SENSITIVE OVARIAN | - |
dc.subject | PLUS CARBOPLATIN | - |
dc.subject | PRIMARY SURGERY | - |
dc.subject | DOUBLE-BLIND | - |
dc.title | Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Sanghoon | - |
dc.contributor.affiliatedAuthor | Kim, Hyun-Jung | - |
dc.identifier.doi | 10.3802/jgo.2018.29.e56 | - |
dc.identifier.scopusid | 2-s2.0-85059795658 | - |
dc.identifier.wosid | 000433285800020 | - |
dc.identifier.bibliographicCitation | JOURNAL OF GYNECOLOGIC ONCOLOGY, v.29, no.4 | - |
dc.relation.isPartOf | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.citation.title | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.citation.volume | 29 | - |
dc.citation.number | 4 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002355178 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.subject.keywordPlus | PEGYLATED LIPOSOMAL DOXORUBICIN | - |
dc.subject.keywordPlus | RECURRENT EPITHELIAL OVARIAN | - |
dc.subject.keywordPlus | PLATINUM-RESISTANT OVARIAN | - |
dc.subject.keywordPlus | PHASE-III TRIAL | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | PRIMARY PERITONEAL | - |
dc.subject.keywordPlus | SENSITIVE OVARIAN | - |
dc.subject.keywordPlus | PLUS CARBOPLATIN | - |
dc.subject.keywordPlus | PRIMARY SURGERY | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordAuthor | Ovarian Neoplasms | - |
dc.subject.keywordAuthor | Practice Guideline | - |
dc.subject.keywordAuthor | Consensus | - |
dc.subject.keywordAuthor | General Surgery | - |
dc.subject.keywordAuthor | Drug Therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.